Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-31

Clinical Trial Update: DermaSensor Postmarket Surveillance Study [NA]

View source ↗

Summary

DermaSensor, Inc. is conducting a postmarket surveillance clinical trial to monitor device performance in melanoma/skin conditions; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DermaSensor

Snippet

Sponsor: DermaSensor, Inc. | Conditions: Melanoma, Skin | NA | Status: RECRUITING